TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Contracts For Comparative NMR Imaging studies Awarded To Five Institutions; NCI Staff Honored June 8, 1984
